GR
Gregory Renza RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
52
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
81.1%
Neutral
18.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $35 |
66%
downside
| 3 | +106% |
0
%
| 23 May ‘25 4 months ago |
|
|
|
Outperform
Reiterated
| $26 |
24%
upside
| 1 | -6.2% |
0
%
| 19 May ‘25 5 months ago |
|
|
|
Outperform
Reiterated
| $8 |
96%
upside
| 1 | +125% |
0
%
| 15 May ‘25 5 months ago |
|
|
|
Sector Perform
Reiterated
| $5 |
113%
upside
| 3 | – |
–
| 14 May ‘25 5 months ago |
|
|
|
Outperform
Reiterated
| $40 |
2%
upside
| 3 | +12% |
0
%
| 14 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $311 |
2%
downside
| 3 | +11% |
0
%
| 8 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $172 |
26%
upside
| 5 | +4.9% |
0
%
| 7 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $32 |
292%
upside
| 2 | -36% |
0
%
| 2 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $320 |
7%
upside
| 3 | +2.2% |
0
%
| 2 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $68 |
64%
upside
| 2 | +16% |
0
%
| 29 Apr ‘25 5 months ago |
|
|
|
Sector Perform
Maintained
| $37.50 |
76%
downside
| 3 | – |
–
| 16 Apr ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $15 |
234%
upside
| 3 | +21% |
0
%
| 27 Mar ‘25 6 months ago |
|
|
|
Outperform
Reiterated
| $12 |
18%
upside
| 2 | +15% |
0
%
| 26 Mar ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $14 |
52%
upside
| 2 | +18% |
0
%
| 21 Mar ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $32 |
117%
upside
| 1 | +2.7% |
0
%
| 27 Feb ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $27 |
174%
upside
| 1 | -50% |
0
%
| 29 Jan ‘25 8 months ago |
|
|
|
Outperform
Reiterated
| $61 |
108%
upside
| 1 | +29% |
0
%
| 15 Jan ‘25 9 months ago |
|
|
|
Sector Perform
Reiterated
| $18 |
21%
downside
| 2 | – |
–
| 14 Jan ‘25 9 months ago |
|
|
|
Outperform
Reiterated
| $10 |
193%
upside
| 2 | +16% |
0
%
| 7 Jan ‘25 9 months ago |
|
|
|
Outperform
Upgraded
| $10 |
83%
upside
| 1 | -7.9% |
0
%
| 19 Dec ‘24 10 months ago |
|
|
|
Outperform
Maintained
| $47 |
94%
upside
| 2 | +10% |
0
%
| 17 Dec ‘24 10 months ago |
|
|
|
Outperform
Maintained
| $57 |
35%
upside
| 2 | -1.7% |
0
%
| 10 Dec ‘24 10 months ago |
|
|
|
Sector Perform
Reiterated
| $4 |
56%
downside
| 1 | – |
–
| 14 Nov ‘24 11 months ago |
|
|
|
Sector Perform
Downgraded
| $20 |
382%
upside
| 1 | -1.4% |
–
| 5 Nov ‘24 11 months ago |
|